Illustration: Natalie Peeples/Axios
PCI Pharma's $10 billion deal and Arcadia's buyout prompt questions about other PE-backed auctions that have seemingly gone quiet.
Why it matters: Launching a sale process is one thing — getting the deal across the finish line is another.
